The immunoprotective activity of interleukin-33 in mouse model of cecal ligation and puncture-induced sepsis

被引:27
作者
Li, Shu [1 ]
Zhu, Feng-Xue [1 ]
Zhao, Xiu-Juan [1 ]
An, You-Zhong [1 ]
机构
[1] Peking Univ, Peoples Hosp, Dept Crit Care Med, 11 Xizhimen South St, Beijing 100871, Xicheng Dist, Peoples R China
关键词
Sepsis; T lymphocyte; Apoptosis; Interleukin-33; APOPTOSIS; IL-33; DEPLETION; ISCHEMIA/REPERFUSION; PATHOPHYSIOLOGY; LYMPHOPENIA; GENERATION; PATHWAYS; CYTOKINE; RECEPTOR;
D O I
10.1016/j.imlet.2015.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphocyte apoptosis plays a pivotal role in sepsis-induced immunosuppression and is the primary cause of high mortality rates. Interleukin-33 is a member of the interleukin-1 family that is involved in the polarization of T cells toward a T helper 2-cell phenotype and may regulate apoptotic cell death. The objective of the present study was to assess the effects of interleukin-33 on T lymphocyte apoptosis in sepsis and determine the mechanisms involved. Sepsis was induced in C57BL/6 mice via a cecal ligation and puncture. Mice were infused with recombinant interleukin-33 protein at 1 h and 6 h after surgery. The mortality rates were evaluated over the subsequent 7 days. In a separate experiment, mice were sacrificed 24 h after surgery. Bacterial burdens in the blood and peritoneal cavity were calculated to assess the bacterial clearance. Liver, lung and renal pathology were observed via transmission electron microscopy. The serum levels of interleukin-6, interleukin-10, interleukin-17, interferon-gamma and tumor necrosis factor-alpha were measured via enzyme-linked immunosorbent assays. The number of T and B lymphocytes, the percentage of apoptotic cells and the expression of Fas, Bcl-2, caspase-3, caspase-8 and caspase-9 in CD3(+) T lymphocytes were analyzed by flow cytometry. Interleukin-33 enhanced bacterial clearance, attenuated the severity of organ damage and improved the survival of septic mice. Interleukin-33 decreased the levels of interleukin-6, interleukin-10, interferon-gamma and tumor necrosis factor-a, and it increased the levels of interleukin-17. Interleukin-33 also inhibited the apoptosis of CD4(+) and CD8(+) T lymphocytes and CD19(+) B cells in the spleen. The number of CD3(+) T cells was higher and the expression of active caspase-3, caspase-8 and caspase-9 was lower in the interleukin-33 group compared to the CLP group. The expression of Fas was lower and the expression of Bcl-2 was higher in the interleukin-33 group than in the CLP group. Interleukin-33 prevented apoptosis of T lymphocytes and improved survival in a mouse model of sepsis. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 35 条
[1]   Ways of dying: multiple pathways to apoptosis [J].
Adams, JM .
GENES & DEVELOPMENT, 2003, 17 (20) :2481-2495
[2]   Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection [J].
Alves-Filho, Jose C. ;
Sonego, Fabiane ;
Souto, Fabricio O. ;
Freitas, Andressa ;
Verri, Waldiceu A., Jr. ;
Auxiliadora-Martins, Maria ;
Basile-Filho, Anibal ;
McKenzie, Andrew N. ;
Xu, Damo ;
Cunha, Fernando Q. ;
Liew, Foo Y. .
NATURE MEDICINE, 2010, 16 (06) :708-U113
[3]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[4]   Induction and effector functions of TH17 cells [J].
Bettelli, Estelle ;
Korn, Thomas ;
Oukka, Mohamed ;
Kuchroo, Vijay K. .
NATURE, 2008, 453 (7198) :1051-1057
[5]   Severe Sepsis and Septic Shock REPLY [J].
Angus, Derek C. ;
van der Poll, Tom .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) :2063-2063
[6]   Cytokine cascade in sepsis [J].
Cavaillon, JM ;
Adib-Conquy, M ;
Fitting, C ;
Adrie, C ;
Payen, D .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (09) :535-544
[7]  
CHAUDRY IH, 1979, SURGERY, V85, P205
[8]   Increased Percentages of T Helper Cells Producing IL-17 and Monocytes Expressing Markers of Alternative Activation in Patients with Sepsis [J].
Colo Brunialti, Milena Karina ;
Santos, Michelle Carolina ;
Rigato, Otelo ;
Machado, Flavia Ribeiro ;
Silva, Eliezer ;
Salomao, Reinaldo .
PLOS ONE, 2012, 7 (05)
[9]   Novel therapies for sepsis: A review [J].
Deans, KJ ;
Haley, M ;
Natanson, C ;
Eichacker, PQ ;
Minneci, PC .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (04) :867-874
[10]   Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepis and multiple organ failure [J].
Felmet, KA ;
Hall, MW ;
Clark, RSB ;
Jaffe, R ;
Carcillo, JA .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3765-3772